The Transaortic Approach for Transcatheter Aortic Valve Replacement
| Autor: | Donald Williams, Mauricio G. Cohen, William W. O'Neill, Alexis Rodriguez, Roger G. Carillo, Conrad Macon, Carlos Alfonso, Alan W. Heldman, Joel A. Lardizabal, Martin S. Bilsker, Harit Desai, Brian P. O'Neill, Claudia Martinez |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment medicine.disease Intensive care unit law.invention Surgery Stenosis Valve replacement law Internal medicine Severity of illness medicine Cardiology Myocardial infarction Cardiology and Cardiovascular Medicine Prospective cohort study business Survival rate Stroke |
| Zdroj: | Journal of the American College of Cardiology. 61:2341-2345 |
| ISSN: | 0735-1097 |
| DOI: | 10.1016/j.jacc.2013.02.076 |
| Popis: | Objectives This study sought to investigate the technical feasibility and safety of the transaortic (TAO) transcatheter aortic valve replacement (TAVR) approach in patients not eligible for transfemoral (TF) access by using a device commercially available in the United States. Background A large proportion of candidates for TAVR have inadequate iliofemoral vessels for TF access. The transapical route (TAP) is the current alternative but is associated with less favorable outcomes. Other access options need to be explored. Methods Forty-four consecutive patients with inoperable, severe aortic stenosis underwent TAO TAVR in our institution. Procedural and 30-day clinical outcomes data were compared with data from 76 consecutive patients who underwent TAP TAVR at our site. Technical learning curves were assessed by comparing outcomes of the first 20 cases with the subsequent patients who underwent each procedure. Results The TAO and TAP TAVR groups were similar in terms of device success according to Valve Academic Research Consortium criteria (89% vs. 84%; p = 0.59) and rates of the 30-day combined safety endpoint of all-cause mortality, myocardial infarction, major stroke, disabling bleeding, severe acute kidney injury, and valve reintervention (20% vs. 33%; p = 0.21). The TAO approach, compared with TAP TAVR, was associated with lower combined bleeding and vascular event rate (27% vs. 46%; p = 0.05), shorter median intensive care unit length of stay (3 vs. 6 days; p = 0.01), and a favorable learning curve. Conclusions TAVR via the TAO approach is technically feasible, seems to be associated with favorable outcomes, and expands the current alternative options for access sites in patients with inoperable aortic stenosis who are ineligible for TF TAVR. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|